Abstract:Introduction Microbubble-enhanced burst-mode focused ultrasound (FUS) has been reported to be able to transiently and locally disrupt the blood-brain barrier (BBB), which opens a wide spectrum of opportunity for delivering therapeutic agent into the brain [1]. Magnetic resonance imaging has been recognized to serve as a post-operational evaluation tools for evaluate BBB disruption, such as the use of dynamic contrast-enhanced MRI (DCE-MRI) to identify BBB-disrupted region. Besides of DCE-MRI, MR perfusion/permeability analysis may also provide valuable information to explore the pharmacokinetics/pharmacodynamics (PK/PD) of the delivered drugs of this approach. This may be particularly essential when FUS-induced BBB disruption only sustained for a limited duration (usually a few hours) and the permeability during this period is highly dynamic. The purpose of this study is to evaluate perfusion/permeability change in the FUS-induced BBB disruption process. Material and method Six Sprague-Dawley Rats of either age (300±25g) were used in this study. Each Rat was under isoflurane anesthesia first. A spherically focused ultrasound transducer (400 kHz, diameter/curvature radius = 60/80 mm) was used to transcranially sonicate one hemisphere of rat (peak pressure = 0.4MPa, burst length = 10 ms, PRF = 1 Hz, duration = 90s) in the presence of microbubbles (Sonovue, Bracco; 0.025 mL/kg IV injection). After sonication, animals were immediately moved to MR bore and conducted post-operational MRI scan (7T, ClinScan 70/30 USR, Bruker) for 10 mins. immediately with bolus injection of gadolinium-based MR contrast agent from tail vein (Agnevist, Bayer Healthcare, 0.5ml/kg). Two Dynamic susceptibility-contrast (DSC)-MRI were acquired at 10/150 mins. after BBB-disruption (3D FLASH T1-weighted sequence, TE/TR = 0.76 ms/ 2.31 ms; slice thickness = 0.8 mm; flip angles = 5°/20°; matrix size:192×132). Perfusion/permeability information were obtained based on data post analysis using the Extended-Kety model [2] to generate permeability information including the Ktrans (represents vessel permeability change) and Ve (represents extravascular-extracellular space change) map. ROIs of Ktrans and Ve maps obtained from experimental and contralateral brains were selected for statistic analysis. Result/ Discussion A representative images sets showing the Ktrans/ Ve distribution was demonstrated (Fig. 1a-1d).The dynamic change of Ktrans/ Ve can be demonstrated when comparing Ktrans/ Ve maps acquired at 10 and 150 min. Both Ktrans and Ve presents a local enhancement at the BBB-disrupted site when compared to the right hemisphere, implies that both vessel permeability and extravascular-extracellular space were altered. Distribution of local Ktrans/ Ve differed, also implies that the local vessel permeability and extravascular-extracellular space change were heterogeneous and independent, and may depend on the vessel/ extravascular space volume fraction difference. When observing at 150 min. after FUS sonicaiton, both Ktrans/ Ve change at the BBB-disrupted region dropped apparently. The mean Ktrans values at the target ROI at 10/150 mins. were 4.2×10 /1.7×10 , showing a decrease about 60%; the mean Ve value of at the target ROI were 2.58×10 /0.9×10 and was also decrease 64%. This implies the local permeability change induced from FUS-induced BBB-disruption were highly dynamic. Conclusion Our results provide evidence that FUS-induced BBB disruption induce dynamic perfusion/ permeability increase within a limited time period (> 60% within 150 min). This information also provides useful insights that an optimal drug-delivering procedure should be design to meet the limited high-permeability change window in the focused-ultrasound induced brain drug delivery.

CMUT as a Transmitter for Microbubble-Assisted Blood-Brain Barrier Opening

A High Sensitivity CMUT-Based Passive Cavitation Detector for Monitoring Microbubble Dynamics During Focused Ultrasound Interventions

CMUT for ultrafast passive cavitation detection during ultrasound-induced blood-brain barrier disruption: proof of concept study

The impact of pulse repetition frequency on microbubble activity and drug delivery during focused ultrasound-mediated blood-brain barrier opening

Multimodal evaluation of blood-brain barrier opening in mice in response to low-intensity ultrasound and a claudin-5 binder

Investigation of Sonication Parameters for Large-Volume Focused Ultrasound-Mediated Blood–Brain Barrier Permeability Enhancement Using a Clinical-Prototype Hemispherical Phased Array

A Transmit-Receive Phased Array for Microbubble-Mediated Focused Ultrasound Brain Therapy in Small Animals

Focused Ultrasound Combined with Microbubbles in Central Nervous System Applications

Feasibility of Ultrasound-Induced Blood-Brain Barrier Disruption with a Single-Element Transducer under Three Different Frequencies in Two Non-Human Primates in Vivo: Case Report.

Applications of focused ultrasound-mediated blood-brain barrier opening

Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation

A new safety index based on intrapulse monitoring of ultra-harmonic cavitation during ultrasound-induced blood-brain barrier opening procedures

Magnetic-Resonance Analysis of Dynamic Permeability Change in Focused-Ultrasound Induced Blood-Brain Barrier Disruption in Small Animals

Effect of Microbubble Size, Composition and Multiple Sonication Points on Sterile Inflammatory Response in Focused Ultrasound-Mediated Blood-Brain Barrier Opening

Monitoring Blood-Brain Barrier Opening in Rats with a Preclinical Focused Ultrasound System

A Multitheragnostic Nanobubble System to Induce Blood-Brain Barrier Disruption with Magnetically Guided Focused Ultrasound.

Magnetic-Resonance Imaging for Kinetic Analysis of Permeability Changes During Focused Ultrasound-Induced Blood-Brain Barrier Opening and Brain Drug Delivery

Microbubble-enhanced transcranial MR-guided focused ultrasound brain hyperthermia: heating mechanism investigation using finite element method

An affordable and easy-to-use focused ultrasound device for noninvasive and high precision drug delivery to the mouse brain

Comprehensive assessment of blood–brain barrier opening and sterile inflammatory response: unraveling the therapeutic window

Characterization of different bubble formulations for blood-brain barrier opening using a focused ultrasound system with acoustic feedback control